CoChat

Peripheral and systemic antigens elicit an expandable pool of resident memory CD8 + T cells in the bone marrow

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

BM has been put forward as a major reservoir for memory CD8 + T cells. In order to fulfill that function, BM should “store” memory CD8 + T cells, which in biological terms would require these “stored” memory cells to be in disequilibrium with the circulatory pool. This issue is a matter of ongoing debate. Here, we unequivocally demonstrate that murine and human BM harbors a population of tissue‐resident memory CD8 + T (T RM ) cells. These cells develop against various pathogens, independently of BM infection or local antigen recognition. BM CD8 + T RM cells share a transcriptional program with resident lymphoid cells in other tissues; they are polyfunctional cytokine producers and dependent on IL‐15, Blimp‐1, and Hobit. CD8 + T RM cells reside in the BM parenchyma, but are in close contact with the circulation. Moreover, this pool of resident T cells is not size‐restricted and expands upon peripheral antigenic re‐challenge. This works extends the role of the BM in the maintenance of CD8 + T cell memory to include the preservation of an expandable reservoir of functional, non‐recirculating memory CD8 + T cells, which develop in response to a large variety of peripheral antigens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201848003

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Memory CD8+ T cells with a resident phenotype are present in murine BM after acute systemic infection. (A–C) Spleen and BM were analyzed for virus‐specific CD8 T cells, 172 days after systemic infection with LCMV Armstrong. Data are shown for one representative experiment with n = 4 mice, out of three independent experiments; (A) Frequency of LCMV GP33‐41‐specific and NP396‐404‐specific CD8+ T cells of all CD44+ CD8+ T cells (average + SD); (B) Representative FACS staining for CD69 and CD62L on LCMV GP33‐41‐specific CD44+ CD8+ T cells from spleen and BM; (C) Paired analysis for the percentage of CD62L− CD69+ cells of all LCMV GP33‐41‐specific or NP396‐404‐specific memory CD8+ T cells in spleen versus BM. (D–F) Analysis of OVA‐specific CD8 T cells in spleen and BM of WT mice, 49 days after systemic infection with Listeria‐OVA. Data are shown for one representative experiment with n = 9 mice, out of two independent experiments; (D) Frequency of OVA257‐264‐specific CD8+ T cells of all CD44+ CD8+ T cells (average + SD); (E) Representative FACS staining for CD69 and CD62L on OVA257‐264‐specific CD44+CD8+ T cells from spleen and BM; (F) Paired analysis for the percentage of CD62L+ CD69+ cells of all OVA257‐264‐specific memory CD8+ T cells in spleen vs BM. (G–I) Expression levels of (G) CXCR3, (H) CXCR6, and (I) CX3CR1 in Db‐GP33‐41‐specific memory CD8+ T cell subsets in BM, 60 days after systemic infection with LCMV Armstrong. Data are shown for one representative experiment with n = 10 mice, out of two independent experiments. Data were analyzed by two‐tailed t‐test, with matching (D, F), one‐way ANOVA followed by Tukey's multiple comparisons test (G–I) and two‐way ANOVA, with matching, followed by Bonferroni's multiple comparison test (C). Significance is indicated by *p < 0.05; **p < 0.01; and ****p<0.0001.
Figure 1 Memory CD8+ T cells with a resident phenotype are present in murine BM after acute systemic infection. (A–C) Spleen and BM were analyzed for virus‐specific CD8 T cells, 172 days after systemic infection with LCMV Armstrong. Data are shown for one representative experiment with n = 4 mice, out of three independent experiments; (A) Frequency of LCMV GP33‐41‐specific and NP396‐404‐specific CD8+ T cells of all CD44+ CD8+ T cells (average + SD); (B) Representative FACS staining for CD69 and CD62L on LCMV GP33‐41‐specific CD44+ CD8+ T cells from spleen and BM; (C) Paired analysis for the percentage of CD62L− CD69+ cells of all LCMV GP33‐41‐specific or NP396‐404‐specific memory CD8+ T cells in spleen versus BM. (D–F) Analysis of OVA‐specific CD8 T cells in spleen and BM of WT mice, 49 days after systemic infection with Listeria‐OVA. Data are shown for one representative experiment with n = 9 mice, out of two independent experiments; (D) Frequency of OVA257‐264‐specific CD8+ T cells of all CD44+ CD8+ T cells (average + SD); (E) Representative FACS staining for CD69 and CD62L on OVA257‐264‐specific CD44+CD8+ T cells from spleen and BM; (F) Paired analysis for the percentage of CD62L+ CD69+ cells of all OVA257‐264‐specific memory CD8+ T cells in spleen vs BM. (G–I) Expression levels of (G) CXCR3, (H) CXCR6, and (I) CX3CR1 in Db‐GP33‐41‐specific memory CD8+ T cell subsets in BM, 60 days after systemic infection with LCMV Armstrong. Data are shown for one representative experiment with n = 10 mice, out of two independent experiments. Data were analyzed by two‐tailed t‐test, with matching (D, F), one‐way ANOVA followed by Tukey's multiple comparisons test (G–I) and two‐way ANOVA, with matching, followed by Bonferroni's multiple comparison test (C). Significance is indicated by *p < 0.05; **p < 0.01; and ****p<0.0001.CC BY-NC-ND · PubMed Central
Figure 2 Generation of BM CD8+ TRM cells does not require local infection or antigen presentation. (A) Percentage of CD69+ CD62L− cells within Influenza NP366‐374‐specific CD44+ CD8+ T cells in spleen and BM 33 days after intranasal infection with Influenza A/HKx31. Data are shown from one representative experiment with n = 5 mice, out of two independent experiments; (B) Naïve WT mice were epicutaneously infected with HSV‐1 one day after i.v. transfer of 5 × 104 gBT‐I CD8+ T cells, which recognize the HSV‐1 Kb‐gB498‐505 epitope and are identified as Vα2+ Thy1.1+. Expression of CD69 was analyzed on donor cells in spleen and BM 40 days after infection; (C) Percentage of CD69+ within gBT‐I CD8+ T cells in spleen and BM, 11 months after in vitro activation and transfer; for (B) and (C), experiments were performed twice. (D) Frequency of gBT‐I cells within total CD8α + cells in the spleen (left) or CD69+ within gBT‐I cells in the BM (right) of conjoined mice that received gBT‐I and were subsequently infected with HSV, as shown in (B); (E) Frequency of gBT‐I cells within total CD8α + cells in the spleen (left) or CD69+ within gBT‐I cells in the BM (right) of conjoined mice that received in vitro activated gBT‐I cells, as shown in (C). For (D) and (E), organs were analyzed 3 weeks after conjoining. For (D) and (E), data are shown from one experiment with n = 3 mice. Data were analyzed by two‐tailed t‐test, with matching. Significance is indicated by *p < 0.05 and **p < 0.01.
Figure 2 Generation of BM CD8+ TRM cells does not require local infection or antigen presentation. (A) Percentage of CD69+ CD62L− cells within Influenza NP366‐374‐specific CD44+ CD8+ T cells in spleen and BM 33 days after intranasal infection with Influenza A/HKx31. Data are shown from one representative experiment with n = 5 mice, out of two independent experiments; (B) Naïve WT mice were epicutaneously infected with HSV‐1 one day after i.v. transfer of 5 × 104 gBT‐I CD8+ T cells, which recognize the HSV‐1 Kb‐gB498‐505 epitope and are identified as Vα2+ Thy1.1+. Expression of CD69 was analyzed on donor cells in spleen and BM 40 days after infection; (C) Percentage of CD69+ within gBT‐I CD8+ T cells in spleen and BM, 11 months after in vitro activation and transfer; for (B) and (C), experiments were performed twice. (D) Frequency of gBT‐I cells within total CD8α + cells in the spleen (left) or CD69+ within gBT‐I cells in the BM (right) of conjoined mice that received gBT‐I and were subsequently infected with HSV, as shown in (B); (E) Frequency of gBT‐I cells within total CD8α + cells in the spleen (left) or CD69+ within gBT‐I cells in the BM (right) of conjoined mice that received in vitro activated gBT‐I cells, as shown in (C). For (D) and (E), organs were analyzed 3 weeks after conjoining. For (D) and (E), data are shown from one experiment with n = 3 mice. Data were analyzed by two‐tailed t‐test, with matching. Significance is indicated by *p < 0.05 and **p < 0.01.CC BY-NC-ND · PubMed Central
Figure 3 Virus‐specific resident‐like CD8+ T cells are found within human BM. (A) Representative staining for CD69 and CD103 on CD8+ CD3+ T cells in human BM; (B and C) Expression of chemokine receptors CXCR6, CCR5, and CX3CR1 on CD69− and CD69+ CD8+ T cells in human BM; (B) Representative histograms for CD69− and CD69+ CD8+ T cells; (C) Expression levels depicted as geoMFI for the same populations. For (A–C), data are shown for n = 4 non‐HLA typed BM samples from four different donors; (D) Combinatorial coding analysis of human CD8+ BM T cells specific for CMV or EBV. Dually labelled MHC‐I tetramers loaded with the same immunodominant peptide from either CMV‐VTE, CMV‐TPR, or EBV‐RAK identify virus‐specific CD8+ T cells from BM of HLA‐typed donor #1 (percentages of specific cells is indicated in the gate); (E–G) Quantification of CMV‐ or EBV‐specific CD8 T cells and the percentage of CD69+ cells therein, in human BM. Data are shown for n = 5 HLA‐typed BM samples from five different donors; (E) Table describes detailed information on each specific T cell population detected; (F) The percentage of Tet+ cells detected within total CD8+ cells. For (F) and (G), results are shown as average ± SD. In panel (G), only those samples are indicated for which >100 CD69+ tetramer+ CD8+ T cells were acquired. Data was analyzed by one‐way ANOVA followed by Tukey's multiple comparisons test (G) and two‐way ANOVA, with matching, followed by Bonferroni's multiple comparison test (C). Significance is indicated by *p < 0.05 and **p < 0.01.
Figure 3 Virus‐specific resident‐like CD8+ T cells are found within human BM. (A) Representative staining for CD69 and CD103 on CD8+ CD3+ T cells in human BM; (B and C) Expression of chemokine receptors CXCR6, CCR5, and CX3CR1 on CD69− and CD69+ CD8+ T cells in human BM; (B) Representative histograms for CD69− and CD69+ CD8+ T cells; (C) Expression levels depicted as geoMFI for the same populations. For (A–C), data are shown for n = 4 non‐HLA typed BM samples from four different donors; (D) Combinatorial coding analysis of human CD8+ BM T cells specific for CMV or EBV. Dually labelled MHC‐I tetramers loaded with the same immunodominant peptide from either CMV‐VTE, CMV‐TPR, or EBV‐RAK identify virus‐specific CD8+ T cells from BM of HLA‐typed donor #1 (percentages of specific cells is indicated in the gate); (E–G) Quantification of CMV‐ or EBV‐specific CD8 T cells and the percentage of CD69+ cells therein, in human BM. Data are shown for n = 5 HLA‐typed BM samples from five different donors; (E) Table describes detailed information on each specific T cell population detected; (F) The percentage of Tet+ cells detected within total CD8+ cells. For (F) and (G), results are shown as average ± SD. In panel (G), only those samples are indicated for which >100 CD69+ tetramer+ CD8+ T cells were acquired. Data was analyzed by one‐way ANOVA followed by Tukey's multiple comparisons test (G) and two‐way ANOVA, with matching, followed by Bonferroni's multiple comparison test (C). Significance is indicated by *p < 0.05 and **p < 0.01.CC BY-NC-ND · PubMed Central
Figure 4 Murine steady‐state BM lodges CD8+ T cell memory‐like cells with a resident phenotype. (A–D) Analysis of the CD8+ T cell memory‐like compartment in adult mice under SPF breeding. Data are shown for 1 experiment with n = 5 mice; (A) Frequency of memory CD44+ cells within CD8αβ + TCRβ + T cells in peripheral blood (PB), spleen, and BM; (B) Frequency of CD69+ cells of all CD44+ CD8αβ + TCRβ + T cells; (C) Representative FACS plots showing expression of CD62L and CD69 on memory CD8 T cells (defined as CD44+ CD8αβ + TCRβ + cells) in the different organs; (D) Frequency of memory CD8+ T cells subsets in spleen and BM, as gated for in panel C; (E–H) Relative mRNA expression of (E) Ccr7, (F) Klf2, (G) S1pr1, and (H) Hobit relative to the housekeeping gene Cyclophilin A in sort‐purified memory CD8+ T cell subsets from BM, as defined in (C) and (D). Data is shown for four independent sorting experiments, each with pooled BM from n = 4 mice; (I) Heatmap of RNA sequencing data for the 30 genes that compose the universal transcriptional signature of lymphocyte tissue residency 13 in CD8+ TNV (CD44− CD62L+), TCM (CD44+ CD62L+), TEM (CD44+ CD62L− CD69−), and TRM (CD44+ CD62L− CD69+) cells that were sort‐purified from BM of naïve mice. Data are shown from three independent sorting experiments, each with pooled BM from n = 6 mice. Relative expression levels (Z‐scores) of genes are shown, color coded according to legend. Data are shown as mean ± SD (A and B) or mean ± SEM (E–H). Statistical analysis was performed with one‐way ANOVA followed by Tukey's multiple comparisons test (A and B) and two‐way ANOVA followed by Bonferroni's multiple comparison test (D–H). Significance is indicated by *p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001.
Figure 4 Murine steady‐state BM lodges CD8+ T cell memory‐like cells with a resident phenotype. (A–D) Analysis of the CD8+ T cell memory‐like compartment in adult mice under SPF breeding. Data are shown for 1 experiment with n = 5 mice; (A) Frequency of memory CD44+ cells within CD8αβ + TCRβ + T cells in peripheral blood (PB), spleen, and BM; (B) Frequency of CD69+ cells of all CD44+ CD8αβ + TCRβ + T cells; (C) Representative FACS plots showing expression of CD62L and CD69 on memory CD8 T cells (defined as CD44+ CD8αβ + TCRβ + cells) in the different organs; (D) Frequency of memory CD8+ T cells subsets in spleen and BM, as gated for in panel C; (E–H) Relative mRNA expression of (E) Ccr7, (F) Klf2, (G) S1pr1, and (H) Hobit relative to the housekeeping gene Cyclophilin A in sort‐purified memory CD8+ T cell subsets from BM, as defined in (C) and (D). Data is shown for four independent sorting experiments, each with pooled BM from n = 4 mice; (I) Heatmap of RNA sequencing data for the 30 genes that compose the universal transcriptional signature of lymphocyte tissue residency 13 in CD8+ TNV (CD44− CD62L+), TCM (CD44+ CD62L+), TEM (CD44+ CD62L− CD69−), and TRM (CD44+ CD62L− CD69+) cells that were sort‐purified from BM of naïve mice. Data are shown from three independent sorting experiments, each with pooled BM from n = 6 mice. Relative expression levels (Z‐scores) of genes are shown, color coded according to legend. Data are shown as mean ± SD (A and B) or mean ± SEM (E–H). Statistical analysis was performed with one‐way ANOVA followed by Tukey's multiple comparisons test (A and B) and two‐way ANOVA followed by Bonferroni's multiple comparison test (D–H). Significance is indicated by *p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001.CC BY-NC-ND · PubMed Central
Figure 5 Specific features of BM CD8+ TRM cells. (A–D) Analysis of RNA sequencing data obtained for CD8+ TNV (CD44− CD62L+), TCM (CD44+ CD62L+), TEM (CD44+ CD62L− CD69−), and TRM (CD44+ CD62L− CD69+) cells that were sort‐purified from BM of naïve mice. Data are shown from three independent sorting experiments, each with pooled BM from n = 6 mice; (A) Number of differentially expressed (DE) genes (downregulated in white, upregulated in black) between TRM versus TEM, TRM versus TCM, and TRM versus TNV. DE expressed genes were specifically up‐ or downregulated in BM TRM in comparison to their circulating counterparts, as determined by RNA sequencing (fold change [FC] > 1.5; and reads per kilobase per million mapped reads (RPKM) > 8]; (B) Venn diagram showing the overlap between genes DE by TRM and TEM, TRM, and TCM cells; (C) Heatmap displays relative amounts of transcripts of the 39 DE genes that were shared in the comparison shown in (B). Relative expression levels (Z‐scores) of genes are shown, color coded according to legend; (D) Correlation of gene ontology (GO)‐terms enriched in the sum of DE expressed genes between TRM versus TEM and TRM versus TCM (547 DE genes, FC > 1.5; RPKM = 8). GO‐terms were filtered to contain between 20 and 100 genes. Enrichment analysis revealed enrichment of the DE genes in 104 GO‐terms, which clustered into nine groups by comparison of their overlap index. Results are shown as a heatmap of the overlap indices, with the clustering and a color representation of each group on the left and a representative group name on the right; (E and F) Transcript levels of IFN‐γ in TCM, TEM, and TRM sorted from steady‐state mice, analyzed via RNAseq (E, obtained as in A–D) or RT‐qPCR (F, data are from four different sorting experiments, each with pooled BM from n = 4 mice); (G–I) Production of IFN‐γ by TCM, TEM, or TRM CD8+ T cells from LCMV‐infected mice. BM cells were incubated for 5 h with Brefeldin A in the absence (no stim.) or presence of GP33‐41 peptide and IFN‐γ production was evaluated by ICS in the different memory populations. Data are shown for one representative experiment with n = 4 mice, out of two independent experiments; (G) Representative plots and quantification of the production of IFN‐γ in the absence (H) or presence of LCMV peptide (I); (J and K) Polyfunctionality of TEM and TRM cells was analyzed as in panels (G–I). Data are from one representative experiment with n = 5 mice, out of two independent experiments; (J) Co‐production of IFN‐γ and CCL3 by TEM or TRM CD8+ T cells from LCMV‐infected mice. Representative plots are shown; (K and L) Representative plots (K) and quantification (L) of TEM and TRM capable of simultaneously producing two, three, or four out of four cytokines (IFN‐γ, CCL3, IL‐2, and TNF‐α). Results in (H), (I), and (L) show mean ± SD. Statistical analysis was performed by one‐way ANOVA followed by Tukey's multiple comparisons test. Significance is indicated by **p < 0.01 and ***p < 0.001.
Figure 5 Specific features of BM CD8+ TRM cells. (A–D) Analysis of RNA sequencing data obtained for CD8+ TNV (CD44− CD62L+), TCM (CD44+ CD62L+), TEM (CD44+ CD62L− CD69−), and TRM (CD44+ CD62L− CD69+) cells that were sort‐purified from BM of naïve mice. Data are shown from three independent sorting experiments, each with pooled BM from n = 6 mice; (A) Number of differentially expressed (DE) genes (downregulated in white, upregulated in black) between TRM versus TEM, TRM versus TCM, and TRM versus TNV. DE expressed genes were specifically up‐ or downregulated in BM TRM in comparison to their circulating counterparts, as determined by RNA sequencing (fold change [FC] > 1.5; and reads per kilobase per million mapped reads (RPKM) > 8]; (B) Venn diagram showing the overlap between genes DE by TRM and TEM, TRM, and TCM cells; (C) Heatmap displays relative amounts of transcripts of the 39 DE genes that were shared in the comparison shown in (B). Relative expression levels (Z‐scores) of genes are shown, color coded according to legend; (D) Correlation of gene ontology (GO)‐terms enriched in the sum of DE expressed genes between TRM versus TEM and TRM versus TCM (547 DE genes, FC > 1.5; RPKM = 8). GO‐terms were filtered to contain between 20 and 100 genes. Enrichment analysis revealed enrichment of the DE genes in 104 GO‐terms, which clustered into nine groups by comparison of their overlap index. Results are shown as a heatmap of the overlap indices, with the clustering and a color representation of each group on the left and a representative group name on the right; (E and F) Transcript levels of IFN‐γ in TCM, TEM, and TRM sorted from steady‐state mice, analyzed via RNAseq (E, obtained as in A–D) or RT‐qPCR (F, data are from four different sorting experiments, each with pooled BM from n = 4 mice); (G–I) Production of IFN‐γ by TCM, TEM, or TRM CD8+ T cells from LCMV‐infected mice. BM cells were incubated for 5 h with Brefeldin A in the absence (no stim.) or presence of GP33‐41 peptide and IFN‐γ production was evaluated by ICS in the different memory populations. Data are shown for one representative experiment with n = 4 mice, out of two independent experiments; (G) Representative plots and quantification of the production of IFN‐γ in the absence (H) or presence of LCMV peptide (I); (J and K) Polyfunctionality of TEM and TRM cells was analyzed as in panels (G–I). Data are from one representative experiment with n = 5 mice, out of two independent experiments; (J) Co‐production of IFN‐γ and CCL3 by TEM or TRM CD8+ T cells from LCMV‐infected mice. Representative plots are shown; (K and L) Representative plots (K) and quantification (L) of TEM and TRM capable of simultaneously producing two, three, or four out of four cytokines (IFN‐γ, CCL3, IL‐2, and TNF‐α). Results in (H), (I), and (L) show mean ± SD. Statistical analysis was performed by one‐way ANOVA followed by Tukey's multiple comparisons test. Significance is indicated by **p < 0.01 and ***p < 0.001.CC BY-NC-ND · PubMed Central
Figure 6 BM CD8+ TRM cells reside in the parenchyma in close contact with the circulation. (A and B) Comparison of DE genes between TRM from different organs. RNA sequencing data for BM TRM was acquired as in Fig. 4I, while data for liver, SI, and skin TRM were obtained from ref. [13]; (A) Venn diagram showing the overlap between DE genes by TRM from BM, Liver, SI, and skin, compared to splenic TNV (Sp) (FC > 1.5; RPKM = 8); (B) Correlation plot depicting the similarity between TRM in different organs. The correlation is pairwise, and was calculated using log2 RPKM values of the 136 DE genes that were significant in all four contrasts; (C–E) Intravascular staining to probe the localization of TRM within the BM. Mice were i.v. injected with 3 μg of an antibody against CD8a. Organs were obtained 2 min after injection and processed immediately. Data are shown for one representative experiment with n = 3 mice, out of two independent experiments; (C) A representative histogram comparing the staining with the anti‐CD8α antibody in CD8β + CD44+ cells from spleen, peripheral blood (PB), liver, and BM; geoMFI of CD8α staining in (D) CD8β + CD44+ cells from the different organs or (E) CD8β + memory subsets within the BM; (F and G) Immunofluorescence analysis of (F) CD8α + cells or (G) CD69+ CD8α + cells within steady‐state BM. Scale bar = 50 μm. Vasculature was visualized with antibodies against CD31 and CD144 and nuclei with Helix NP green staining. One representative region from a tile scan of 4 × 7 images is shown. The full tile scan is shown in Supporting Information Fig. 2; 40× magnification. Each CD8a + cell is encircled in white to identify these cells across the different stainings. CD69+ CD8α + cells are marked with an arrow.
Figure 6 BM CD8+ TRM cells reside in the parenchyma in close contact with the circulation. (A and B) Comparison of DE genes between TRM from different organs. RNA sequencing data for BM TRM was acquired as in Fig. 4I, while data for liver, SI, and skin TRM were obtained from ref. [13]; (A) Venn diagram showing the overlap between DE genes by TRM from BM, Liver, SI, and skin, compared to splenic TNV (Sp) (FC > 1.5; RPKM = 8); (B) Correlation plot depicting the similarity between TRM in different organs. The correlation is pairwise, and was calculated using log2 RPKM values of the 136 DE genes that were significant in all four contrasts; (C–E) Intravascular staining to probe the localization of TRM within the BM. Mice were i.v. injected with 3 μg of an antibody against CD8a. Organs were obtained 2 min after injection and processed immediately. Data are shown for one representative experiment with n = 3 mice, out of two independent experiments; (C) A representative histogram comparing the staining with the anti‐CD8α antibody in CD8β + CD44+ cells from spleen, peripheral blood (PB), liver, and BM; geoMFI of CD8α staining in (D) CD8β + CD44+ cells from the different organs or (E) CD8β + memory subsets within the BM; (F and G) Immunofluorescence analysis of (F) CD8α + cells or (G) CD69+ CD8α + cells within steady‐state BM. Scale bar = 50 μm. Vasculature was visualized with antibodies against CD31 and CD144 and nuclei with Helix NP green staining. One representative region from a tile scan of 4 × 7 images is shown. The full tile scan is shown in Supporting Information Fig. 2; 40× magnification. Each CD8a + cell is encircled in white to identify these cells across the different stainings. CD69+ CD8α + cells are marked with an arrow.CC BY-NC-ND · PubMed Central
Figure 7 Maintenance of BM CD8+ TRM cells depends on IL‐15 and Hobit. (A–C) In vitro‐activated gBT‐I cells were transferred into WT or IL‐15−/− mice and, after 30 days, the presence of total gBT‐I and CD69+ gBT‐I was analyzed in the BM. Results are shown as (A) representative plots, (B) quantification of the % of gBT‐I within total CD8α + cells and (C) quantification of TRM (CD69+) cells within gBT‐I cells in the BM, from one experiment with n = 5 WT and 4 IL‐15−/− mice. Results show mean ± SD; experiment was performed twice. (D and E) WT (Blimp+/+ Hobit+/+) or mice deficient for Hobit (Blimp+/+ Hobit−/−), Blimp1 (Blimp−/‐ Hobit+/+), or both (Blimp−/− Hobit−/−) were infected i.n. with Influenza A/HKx31. BM was harvested and analyzed 63 dpi. Results are shown from one representative experiment with n = 5 mice, out of three independent experiments, as (D) percentage of Db‐NP366‐374 + cells within total CD8αβ + T cells and (E) percentage of TRM (CD69+ CD62L−) cells within Db‐NP366‐374 + CD8αβ + T cells. Data were analyzed by two‐tailed t‐test (B and C) or one‐way ANOVA followed by Tukey's multiple comparisons test (D and E). Significance is indicated by *p < 0.05 and **p < 0.01.
Figure 7 Maintenance of BM CD8+ TRM cells depends on IL‐15 and Hobit. (A–C) In vitro‐activated gBT‐I cells were transferred into WT or IL‐15−/− mice and, after 30 days, the presence of total gBT‐I and CD69+ gBT‐I was analyzed in the BM. Results are shown as (A) representative plots, (B) quantification of the % of gBT‐I within total CD8α + cells and (C) quantification of TRM (CD69+) cells within gBT‐I cells in the BM, from one experiment with n = 5 WT and 4 IL‐15−/− mice. Results show mean ± SD; experiment was performed twice. (D and E) WT (Blimp+/+ Hobit+/+) or mice deficient for Hobit (Blimp+/+ Hobit−/−), Blimp1 (Blimp−/‐ Hobit+/+), or both (Blimp−/− Hobit−/−) were infected i.n. with Influenza A/HKx31. BM was harvested and analyzed 63 dpi. Results are shown from one representative experiment with n = 5 mice, out of three independent experiments, as (D) percentage of Db‐NP366‐374 + cells within total CD8αβ + T cells and (E) percentage of TRM (CD69+ CD62L−) cells within Db‐NP366‐374 + CD8αβ + T cells. Data were analyzed by two‐tailed t‐test (B and C) or one‐way ANOVA followed by Tukey's multiple comparisons test (D and E). Significance is indicated by *p < 0.05 and **p < 0.01.CC BY-NC-ND · PubMed Central
Figure 8 The pool of BM CD8+ TRM cells is expandable. (A–C) Distribution of CD8αβ + memory populations specific for mCMV acute and inflationary epitopes analyzed 65 days p.i.; Representative plots are shown for (A) acute epitopes M45 and M57 and (B) inflationary epitopes M38 and m139. Tetramer stainings are shown in the left panels and the gating for TRM (CD62L− CD69+) and TEM (CD62L− CD69−) is shown in the right panels; (C) Percentage of TEM and TRM within live BM cells for each mCMV‐specific population. Data is shown for one representative experiment with n = 4 mice, out of two independent experiments; (D–F) Distribution of OT‐I memory populations analyzed more than 30 days after the last immunization in mice that received one or three homologous boosts to generate OVA‐specific memory. Data are shown for one experiment with n = 5 mice that received one challenge and 4 mice that received three challenges; (D) Schematic depiction of the experimental setup; (E) Percentage of OT‐I cells within total CD8α + cells in the BM; (F) Percentage of TCM, TEM, and TRM within OT‐I cells in the BM after one or three homologous challenges; (G–I) Distribution of OVA‐specific CD8αβ + memory populations analyzed more than 60 days after the first challenge in mice that received only Lm‐OVA or Lm‐OVA followed by LCMV Armstrong infection, more than 30 days after the first challenge. Data are shown for one experiment with n = 5 mice/group. Results from the reverse experiment are shown in Supporting Information Fig. 3; (G) Schematic depiction of the experimental setup; (H) Percentage of Kb‐OVA257‐264 + TRM cells of live BM cells; (I) Percentage of total TRM within live BM cells. Data were analyzed by two‐tailed t‐test (E, H, and I) and two‐way ANOVA, followed by Bonferroni's multiple comparison test (C and F). Significance is indicated by **p < 0.01 and ***p < 0.001.
Figure 8 The pool of BM CD8+ TRM cells is expandable. (A–C) Distribution of CD8αβ + memory populations specific for mCMV acute and inflationary epitopes analyzed 65 days p.i.; Representative plots are shown for (A) acute epitopes M45 and M57 and (B) inflationary epitopes M38 and m139. Tetramer stainings are shown in the left panels and the gating for TRM (CD62L− CD69+) and TEM (CD62L− CD69−) is shown in the right panels; (C) Percentage of TEM and TRM within live BM cells for each mCMV‐specific population. Data is shown for one representative experiment with n = 4 mice, out of two independent experiments; (D–F) Distribution of OT‐I memory populations analyzed more than 30 days after the last immunization in mice that received one or three homologous boosts to generate OVA‐specific memory. Data are shown for one experiment with n = 5 mice that received one challenge and 4 mice that received three challenges; (D) Schematic depiction of the experimental setup; (E) Percentage of OT‐I cells within total CD8α + cells in the BM; (F) Percentage of TCM, TEM, and TRM within OT‐I cells in the BM after one or three homologous challenges; (G–I) Distribution of OVA‐specific CD8αβ + memory populations analyzed more than 60 days after the first challenge in mice that received only Lm‐OVA or Lm‐OVA followed by LCMV Armstrong infection, more than 30 days after the first challenge. Data are shown for one experiment with n = 5 mice/group. Results from the reverse experiment are shown in Supporting Information Fig. 3; (G) Schematic depiction of the experimental setup; (H) Percentage of Kb‐OVA257‐264 + TRM cells of live BM cells; (I) Percentage of total TRM within live BM cells. Data were analyzed by two‐tailed t‐test (E, H, and I) and two‐way ANOVA, followed by Bonferroni's multiple comparison test (C and F). Significance is indicated by **p < 0.01 and ***p < 0.001.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

Metadata

Authors
Pascutti, M. F., Geerman, S., Collins, N., Brasser, G., Nota, B., Stark, R., Behr, F., Oja, A., Slot, E., Panagioti, E., Prier, J. E., Hickson, S., Wolkers, M. C., Heemskerk, M. H. M., Hombrink, P., Arens, R., Mackay, L. K., van Gisbergen, K. P. J. M., & Nolte, M. A.
Affiliations
  • Department of Hematopoiesis Sanquin Research Amsterdam The Netherlands
  • Sanquin (NL)
  • The University of Melbourne (AU)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Leiden University Medical Center (NL)
Corresponding author
Nolte, Martijn A.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2019-04-02
Volume
49
Issue
6
Pages
853-872
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2923107206
Cited by
37
References
64
Citations by year
2026: 5 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 9 · 2020: 4 · 2019: 4
FWCI
1.89
Type
journal article
Language
en
Open access
Locations
  • European Journal of Immunology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Funders
  • Landsteiner Foundation for Blood Transfusion Research
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI #917.13.338)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
tissue-resident memory T cells, CD8+ T cells, bone marrow, IL-15, Blimp-1, Hobit, cytokine production, transcriptional programs, T cell homeostasis
MeSH terms
Animals, Bone Marrow Cells, Humans, Immunologic Memory, Mice, Inbred C57BL, T-Lymphocyte Subsets, CD8-Positive T-Lymphocytes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.